home / stock / gene / gene quote
Last: | $3.16 |
---|---|
Change Percent: | -3.47% |
Open: | $3.28 |
Close: | $3.16 |
High: | $3.28 |
Low: | $3.1 |
Volume: | 13,033 |
Last Trade Date Time: | 04/17/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$3.16 | $3.28 | $3.16 | $3.28 | $3.1 | 13,033 | 04-17-2024 |
$3.17 | $3.27 | $3.17 | $3.3 | $3.045 | 28,303 | 04-16-2024 |
$3.2701 | $3.38 | $3.2701 | $3.38 | $3.21 | 15,770 | 04-15-2024 |
$3.321 | $3.35 | $3.321 | $3.59 | $3.2001 | 42,226 | 04-12-2024 |
$3.2 | $3.05 | $3.2 | $3.2 | $3.0006 | 44,736 | 04-11-2024 |
$2.958 | $3 | $2.958 | $3.03 | $2.885 | 37,481 | 04-10-2024 |
$2.88 | $2.92 | $2.88 | $2.94 | $2.86 | 9,792 | 04-09-2024 |
$2.82 | $2.87 | $2.82 | $2.87 | $2.82 | 3,706 | 04-08-2024 |
$2.78 | $2.898 | $2.78 | $2.898 | $2.71 | 8,828 | 04-05-2024 |
$2.82 | $2.85 | $2.82 | $2.89 | $2.7 | 43,323 | 04-04-2024 |
$2.79 | $2.71 | $2.79 | $2.9 | $2.69 | 34,526 | 04-03-2024 |
$2.71 | $2.95 | $2.71 | $2.95 | $2.7 | 35,108 | 04-02-2024 |
$2.84 | $2.95 | $2.84 | $2.95 | $2.7905 | 22,309 | 04-01-2024 |
$2.89 | $2.8 | $2.89 | $2.94 | $2.8 | 16,068 | 03-29-2024 |
$2.89 | $2.8 | $2.89 | $2.94 | $2.8 | 16,068 | 03-28-2024 |
$2.81 | $2.8 | $2.81 | $2.84 | $2.73 | 36,482 | 03-27-2024 |
$2.71 | $2.53 | $2.71 | $2.71 | $2.53 | 34,425 | 03-26-2024 |
$2.56 | $2.7 | $2.56 | $2.7499 | $2.48 | 37,436 | 03-25-2024 |
$2.67 | $2.53 | $2.67 | $2.8999 | $2.46 | 145,755 | 03-22-2024 |
$2.5 | $2.72 | $2.5 | $2.73 | $2.3601 | 93,190 | 03-21-2024 |
News, Short Squeeze, Breakout and More Instantly...
Genetic Technologies Ltd Company Name:
GENE Stock Symbol:
NASDAQ Market:
MELBOURNE, Australia, April 17, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness and serious disease, is pleased to announce the Company has established a preci...
MELBOURNE, Australia, April 16, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and serious disease, is pleased to share the company’s latest milestone...
ORLANDO, FL / ACCESSWIRE / April 12, 2024 / RedChip Companies will air interviews with Genetic Technologies Limited (NASDAQ:GENE) and BioVie, Inc. (NASDAQ:BIVI) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, April 13, at 7 p.m. Eastern ...